BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26795600)

  • 1. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.
    Choquet H; Trapani E; Goitre L; Trabalzini L; Akers A; Fontanella M; Hart BL; Morrison LA; Pawlikowska L; Kim H; Retta SF
    Free Radic Biol Med; 2016 Mar; 92():100-109. PubMed ID: 26795600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
    Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
    Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.
    Perrelli A; Retta SF
    Free Radic Biol Med; 2021 Aug; 172():403-417. PubMed ID: 34175437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.
    Fontes-Dantas FL; da Fontoura Galvão G; Veloso da Silva E; Alves-Leon S; Cecília da Silva Rêgo C; Garcia DG; Marques SA; Blanco Martinez AM; Reis da Silva M; Marcondes de Souza J
    World Neurosurg; 2020 Jun; 138():535-540.e8. PubMed ID: 32113992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.
    Yang C; Nicholas VH; Zhao J; Wu B; Zhong H; Li Y; Xu Y
    J Mol Neurosci; 2017 Apr; 61(4):511-523. PubMed ID: 28255959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
    Wang H; Pan Y; Zhang Z; Li X; Xu Z; Suo Y; Li W; Wang Y
    J Mol Neurosci; 2017 Feb; 61(2):221-226. PubMed ID: 28160210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
    Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
    Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Genotyping of Cerebral Cavernous Malformation Type 1 Individuals to Identify Genetic Modifiers of Disease Severity.
    Choquet H; Kim H
    Methods Mol Biol; 2020; 2152():77-84. PubMed ID: 32524545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
    Gault J; Sain S; Hu LJ; Awad IA
    Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased number of white matter lesions in patients with familial cerebral cavernous malformations.
    Golden MJ; Morrison LA; Kim H; Hart BL
    AJNR Am J Neuroradiol; 2015 May; 36(5):899-903. PubMed ID: 25556204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation.
    Yang C; Wu B; Zhong H; Li Y; Zheng X; Xu Y
    Clin Neurol Neurosurg; 2018 Jan; 164():44-46. PubMed ID: 29169046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
    Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
    J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation.
    Reddy S; Gorin MB; McCannel TA; Tsui I; Straatsma BR
    Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1359-61. PubMed ID: 20306072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.
    Battistini S; Rocchi R; Cerase A; Citterio A; Tassi L; Lando G; Patrosso MC; Galli R; Brunori P; Sgrò DL; Pitillo G; Lo Russo G; Marocchi A; Penco S
    Arch Neurol; 2007 Jun; 64(6):843-8. PubMed ID: 17562932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel KRIT1/CCM1 mutation accompanied by a NOTCH3 mutation in a Chinese family with multiple cerebral cavernous malformations.
    Li C; Liu P; Huang W; Wang H; Ma K; Zhuo L; Kang Y; He Q; Lin Y; Kang D; Lin F
    Neurogenetics; 2023 Apr; 24(2):137-146. PubMed ID: 36892712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlations in cerebral cavernous malformations patients.
    Denier C; Labauge P; Bergametti F; Marchelli F; Riant F; Arnoult M; Maciazek J; Vicaut E; Brunereau L; Tournier-Lasserve E
    Ann Neurol; 2006 Nov; 60(5):550-556. PubMed ID: 17041941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Report of Concomitant Pathogenic Mutations Within MGC4607/CCM2 and KRIT1/CCM1 in a Familial Cerebral Cavernous Malformation Patient.
    da Fontoura Galvão G; Veloso da Silva E; Fontes-Dantas FL; Filho RC; Alves-Leon S; Marcondes de Souza J
    World Neurosurg; 2020 Oct; 142():481-486.e1. PubMed ID: 32615293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.
    Retta SF; Glading AJ
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):254-270. PubMed ID: 27639680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.